The question everyone asks is simple
The FDA does not discuss its interactions with drugmakers as a matter of general policy, a spokesperson said, so the information exchanged between Eli Lilly and the agency before it determined the tirzepatide shortage was over is unknown
Tirzepatide, marketed under the brand name Mounjaro, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Tirzepatide has also been known to potentially affect (delay) the absorption of oral medications such as oral contraceptive pills
Eli Lilly's testing of compounded tirzepatide products found bacterial contamination, high impurity levels, incorrect active ingredients, and in one case, no active ingredient at all
Dietary modifications : Eating smaller, more frequent meals